Skip to content
SHIP

SHIP

Sustained Health Initiatives of the Philippines

  • Philippine HIV Numbers
  • Blood Makes Noise
    • Is the Future of ARV Treatments Injections?
    • Safety First: Why Condoms are Essential
    • Undetectable Is Our Duty
    • It’s Your Secret (a note on disclosure)
    • The Power of Visibility
    • Frequently Asked Questions
  • Local Guidelines
    • Insurance Commission Circular 2019-30
    • Republic Act No. 11166 (The New AIDS Law)
    • RA 11166 Implementing Rules and Regulations
    • 2018 DOH Memorandum on Treatment Hubs & Primary Care Clinics
    • 2018 ART Guidelines
    • 2018 Rapid HIV Diagnostic Algorithem (rHIVda)
    • HIV Testing Guidelines
    • 2017 Management of the HIV-infected Healthcare worker
    • 2016 Enhancing Linkage to Care of PLHIV
    • 2016 Opportunistic Infections in HIV
    • 2016 Updated Tuberculosis Guidelines
    • 2010 Immunization of PLHIV
  • Programs
    • Connect for Life
    • HIV Telehealth Training Program (http)
    • HIV Primary Care Workshop
    • Increasing Access to Services for PLHIV-PWUD
    • Antiretroviral Therapy – Electronic Consultation (ART-EC)
  • Frequently Asked Questions
    • What are the FAQs on HIV?
    • Where Can I Get an HIV Test?
    • How is our HIV in the Workplace Policy?
    • Who are the HIV Healthcare Providers?
  • SHIP in the News
  • Donate
  • About Us
  • Contact Us
Posted on July 12, 2019September 24, 2019 by SHIPadmin

Protected: M02-S09-L13 Dermatology in HIV

This content is password protected. To view it please enter your password below:

CategoriesTelehealth

Post navigation

Previous PostPrevious M02-S08-L11 Treatment Failure & Resistance
Next PostNext M02-S09-L12 Long Term ART Side Effects
Proudly powered by WordPress